Supplementary Figure 5 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Article Swipe

PDF

Magalie Dosset , Yann Godet , Charline Vauchy , Laurent Beziaud , Yu Chun Lone , Christine Sedlik , Christelle Liard , Émeline Levionnois , Bertrand Clerc , Federico Sandoval , Étienne Daguindau , Simon Wain‐Hobson , Éric Tartour , Pierre Langlade‐Demoyen , Christophe Borg , Olivier Adotévi ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.22445390.v1

PDF file - 26K, UCP2 specific CD4 T cells recognize the mTERT-derived counterpart peptide p568

Related Topics

Concepts

Telomerase Peptide Cancer Cancer research Peptide vaccine Virology Medicine Oncology Internal medicine Biology Immunology Genetics Biochemistry Antigen Epitope Gene

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.22445390.v1
PDF: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_Universal_Cancer_Peptide-Based_Therapeutic_Vaccine_Breaks_Tolerance_against_Telomerase_and_Eradicates_Established_Tumor/22445390/1/files/39896432.pdf
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4361902900

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4361902900

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.22445390.v1

Digital Object Identifier
Title: Supplementary Figure 5 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-31

Full publication date if available
Authors: Magalie Dosset, Yann Godet, Charline Vauchy, Laurent Beziaud, Yu Chun Lone, Christine Sedlik, Christelle Liard, Émeline Levionnois, Bertrand Clerc, Federico Sandoval, Étienne Daguindau, Simon Wain‐Hobson, Éric Tartour, Pierre Langlade‐Demoyen, Christophe Borg, Olivier Adotévi

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.22445390.v1

Publisher landing page
PDF URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_Universal_Cancer_Peptide-Based_Therapeutic_Vaccine_Breaks_Tolerance_against_Telomerase_and_Eradicates_Established_Tumor/22445390/1/files/39896432.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_Universal_Cancer_Peptide-Based_Therapeutic_Vaccine_Breaks_Tolerance_against_Telomerase_and_Eradicates_Established_Tumor/22445390/1/files/39896432.pdf

Direct OA link when available
Concepts: Telomerase, Peptide, Cancer, Cancer research, Peptide vaccine, Virology, Medicine, Oncology, Internal medicine, Biology, Immunology, Genetics, Biochemistry, Antigen, Epitope, Gene

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4361902900
doi	https://doi.org/10.1158/1078-0432.22445390.v1
ids.doi	https://doi.org/10.1158/1078-0432.22445390.v1
ids.openalex	https://openalex.org/W4361902900
fwci
type	preprint
title	Supplementary Figure 5 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10580
topics[0].field.id	https://openalex.org/fields/24
topics[0].field.display_name	Immunology and Microbiology
topics[0].score	0.9933000206947327
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/2403
topics[0].subfield.display_name	Immunology
topics[0].display_name	Immunotherapy and Immune Responses
topics[1].id	https://openalex.org/T10158
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.983299970626831
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	Cancer Immunotherapy and Biomarkers
topics[2].id	https://openalex.org/T12996
topics[2].field.id	https://openalex.org/fields/13
topics[2].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[2].score	0.9606000185012817
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/1305
topics[2].subfield.display_name	Biotechnology
topics[2].display_name	Cancer Research and Treatments
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C94581717
concepts[0].level	3
concepts[0].score	0.8300507664680481
concepts[0].wikidata	https://www.wikidata.org/wiki/Q331839
concepts[0].display_name	Telomerase
concepts[1].id	https://openalex.org/C2779281246
concepts[1].level	2
concepts[1].score	0.5532658100128174
concepts[1].wikidata	https://www.wikidata.org/wiki/Q172847
concepts[1].display_name	Peptide
concepts[2].id	https://openalex.org/C121608353
concepts[2].level	2
concepts[2].score	0.5496755242347717
concepts[2].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[2].display_name	Cancer
concepts[3].id	https://openalex.org/C502942594
concepts[3].level	1
concepts[3].score	0.4743560552597046
concepts[3].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[3].display_name	Cancer research
concepts[4].id	https://openalex.org/C2776789287
concepts[4].level	4
concepts[4].score	0.4527875781059265
concepts[4].wikidata	https://www.wikidata.org/wiki/Q7166532
concepts[4].display_name	Peptide vaccine
concepts[5].id	https://openalex.org/C159047783
concepts[5].level	1
concepts[5].score	0.4202061891555786
concepts[5].wikidata	https://www.wikidata.org/wiki/Q7215
concepts[5].display_name	Virology
concepts[6].id	https://openalex.org/C71924100
concepts[6].level	0
concepts[6].score	0.3552341163158417
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[6].display_name	Medicine
concepts[7].id	https://openalex.org/C143998085
concepts[7].level	1
concepts[7].score	0.34086477756500244
concepts[7].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[7].display_name	Oncology
concepts[8].id	https://openalex.org/C126322002
concepts[8].level	1
concepts[8].score	0.33930087089538574
concepts[8].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[8].display_name	Internal medicine
concepts[9].id	https://openalex.org/C86803240
concepts[9].level	0
concepts[9].score	0.32704633474349976
concepts[9].wikidata	https://www.wikidata.org/wiki/Q420
concepts[9].display_name	Biology
concepts[10].id	https://openalex.org/C203014093
concepts[10].level	1
concepts[10].score	0.2594441771507263
concepts[10].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[10].display_name	Immunology
concepts[11].id	https://openalex.org/C54355233
concepts[11].level	1
concepts[11].score	0.15307751297950745
concepts[11].wikidata	https://www.wikidata.org/wiki/Q7162
concepts[11].display_name	Genetics
concepts[12].id	https://openalex.org/C55493867
concepts[12].level	1
concepts[12].score	0.08368575572967529
concepts[12].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[12].display_name	Biochemistry
concepts[13].id	https://openalex.org/C147483822
concepts[13].level	2
concepts[13].score	0.07488232851028442
concepts[13].wikidata	https://www.wikidata.org/wiki/Q103537
concepts[13].display_name	Antigen
concepts[14].id	https://openalex.org/C195616568
concepts[14].level	3
concepts[14].score	0.0
concepts[14].wikidata	https://www.wikidata.org/wiki/Q128711
concepts[14].display_name	Epitope
concepts[15].id	https://openalex.org/C104317684
concepts[15].level	2
concepts[15].score	0.0
concepts[15].wikidata	https://www.wikidata.org/wiki/Q7187
concepts[15].display_name	Gene
keywords[0].id	https://openalex.org/keywords/telomerase
keywords[0].score	0.8300507664680481
keywords[0].display_name	Telomerase
keywords[1].id	https://openalex.org/keywords/peptide
keywords[1].score	0.5532658100128174
keywords[1].display_name	Peptide
keywords[2].id	https://openalex.org/keywords/cancer
keywords[2].score	0.5496755242347717
keywords[2].display_name	Cancer
keywords[3].id	https://openalex.org/keywords/cancer-research
keywords[3].score	0.4743560552597046
keywords[3].display_name	Cancer research
keywords[4].id	https://openalex.org/keywords/peptide-vaccine
keywords[4].score	0.4527875781059265
keywords[4].display_name	Peptide vaccine
keywords[5].id	https://openalex.org/keywords/virology
keywords[5].score	0.4202061891555786
keywords[5].display_name	Virology
keywords[6].id	https://openalex.org/keywords/medicine
keywords[6].score	0.3552341163158417
keywords[6].display_name	Medicine
keywords[7].id	https://openalex.org/keywords/oncology
keywords[7].score	0.34086477756500244
keywords[7].display_name	Oncology
keywords[8].id	https://openalex.org/keywords/internal-medicine
keywords[8].score	0.33930087089538574
keywords[8].display_name	Internal medicine
keywords[9].id	https://openalex.org/keywords/biology
keywords[9].score	0.32704633474349976
keywords[9].display_name	Biology
keywords[10].id	https://openalex.org/keywords/immunology
keywords[10].score	0.2594441771507263
keywords[10].display_name	Immunology
keywords[11].id	https://openalex.org/keywords/genetics
keywords[11].score	0.15307751297950745
keywords[11].display_name	Genetics
keywords[12].id	https://openalex.org/keywords/biochemistry
keywords[12].score	0.08368575572967529
keywords[12].display_name	Biochemistry
keywords[13].id	https://openalex.org/keywords/antigen
keywords[13].score	0.07488232851028442
keywords[13].display_name	Antigen
language	en
locations[0].id	doi:10.1158/1078-0432.22445390.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_Universal_Cancer_Peptide-Based_Therapeutic_Vaccine_Breaks_Tolerance_against_Telomerase_and_Eradicates_Established_Tumor/22445390/1/files/39896432.pdf
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.22445390.v1
locations[1].id	pmh:oai:figshare.com:article/22445390
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_Universal_Cancer_Peptide-Based_Therapeutic_Vaccine_Breaks_Tolerance_against_Telomerase_and_Eradicates_Established_Tumor/22445390
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5043542292
authorships[0].author.orcid	https://orcid.org/0000-0002-3531-4371
authorships[0].author.display_name	Magalie Dosset
authorships[0].author_position	first
authorships[0].raw_author_name	Magalie Dosset
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5089208521
authorships[1].author.orcid	https://orcid.org/0000-0003-4017-6070
authorships[1].author.display_name	Yann Godet
authorships[1].author_position	middle
authorships[1].raw_author_name	Yann Godet
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5036429066
authorships[2].author.orcid
authorships[2].author.display_name	Charline Vauchy
authorships[2].author_position	middle
authorships[2].raw_author_name	Charline Vauchy
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5075650598
authorships[3].author.orcid	https://orcid.org/0000-0001-8526-3261
authorships[3].author.display_name	Laurent Beziaud
authorships[3].author_position	middle
authorships[3].raw_author_name	Laurent Beziaud
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5063305158
authorships[4].author.orcid	https://orcid.org/0000-0002-7417-4930
authorships[4].author.display_name	Yu Chun Lone
authorships[4].author_position	middle
authorships[4].raw_author_name	Yu Chun Lone
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5063854495
authorships[5].author.orcid	https://orcid.org/0000-0001-8502-0905
authorships[5].author.display_name	Christine Sedlik
authorships[5].author_position	middle
authorships[5].raw_author_name	Christine Sedlik
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5050371738
authorships[6].author.orcid
authorships[6].author.display_name	Christelle Liard
authorships[6].author_position	middle
authorships[6].raw_author_name	Christelle Liard
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5074735464
authorships[7].author.orcid
authorships[7].author.display_name	Émeline Levionnois
authorships[7].author_position	middle
authorships[7].raw_author_name	Emeline Levionnois
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5110967089
authorships[8].author.orcid
authorships[8].author.display_name	Bertrand Clerc
authorships[8].author_position	middle
authorships[8].raw_author_name	Bertrand Clerc
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5081251214
authorships[9].author.orcid
authorships[9].author.display_name	Federico Sandoval
authorships[9].author_position	middle
authorships[9].raw_author_name	Federico Sandoval
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5042424335
authorships[10].author.orcid	https://orcid.org/0000-0001-7375-5656
authorships[10].author.display_name	Étienne Daguindau
authorships[10].author_position	middle
authorships[10].raw_author_name	Etienne Daguindau
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5013201108
authorships[11].author.orcid	https://orcid.org/0000-0002-6406-3858
authorships[11].author.display_name	Simon Wain‐Hobson
authorships[11].author_position	middle
authorships[11].raw_author_name	Simon Wain-Hobson
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5018415934
authorships[12].author.orcid	https://orcid.org/0000-0002-7323-468X
authorships[12].author.display_name	Éric Tartour
authorships[12].author_position	middle
authorships[12].raw_author_name	Eric Tartour
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5006417997
authorships[13].author.orcid
authorships[13].author.display_name	Pierre Langlade‐Demoyen
authorships[13].author_position	middle
authorships[13].raw_author_name	Pierre Langlade-Demoyen
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5022288769
authorships[14].author.orcid	https://orcid.org/0000-0001-6161-0169
authorships[14].author.display_name	Christophe Borg
authorships[14].author_position	middle
authorships[14].raw_author_name	Christophe Borg
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5060518732
authorships[15].author.orcid	https://orcid.org/0000-0002-7742-136X
authorships[15].author.display_name	Olivier Adotévi
authorships[15].author_position	last
authorships[15].raw_author_name	Olivier Adotévi
authorships[15].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_Universal_Cancer_Peptide-Based_Therapeutic_Vaccine_Breaks_Tolerance_against_Telomerase_and_Eradicates_Established_Tumor/22445390/1/files/39896432.pdf
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figure 5 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10580
primary_topic.field.id	https://openalex.org/fields/24
primary_topic.field.display_name	Immunology and Microbiology
primary_topic.score	0.9933000206947327
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2403
primary_topic.subfield.display_name	Immunology
primary_topic.display_name	Immunotherapy and Immune Responses
related_works	https://openalex.org/W38648996, https://openalex.org/W2403399378, https://openalex.org/W2020995651, https://openalex.org/W2043713674, https://openalex.org/W1995555192, https://openalex.org/W4241189537, https://openalex.org/W3150349444, https://openalex.org/W2050296416, https://openalex.org/W1600373583, https://openalex.org/W1997341897
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/1078-0432.22445390.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_Universal_Cancer_Peptide-Based_Therapeutic_Vaccine_Breaks_Tolerance_against_Telomerase_and_Eradicates_Established_Tumor/22445390/1/files/39896432.pdf
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.22445390.v1
primary_location.id	doi:10.1158/1078-0432.22445390.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_Universal_Cancer_Peptide-Based_Therapeutic_Vaccine_Breaks_Tolerance_against_Telomerase_and_Eradicates_Established_Tumor/22445390/1/files/39896432.pdf
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.22445390.v1
publication_date	2023-03-31
publication_year	2023
referenced_works_count	0
abstract_inverted_index.-	2
abstract_inverted_index.T	7
abstract_inverted_index.CD4	6
abstract_inverted_index.the	10
abstract_inverted_index.26K,	3
abstract_inverted_index.UCP2	4
abstract_inverted_index.file	1
abstract_inverted_index.cells	8
abstract_inverted_index.peptide	13
abstract_inverted_index.specific	5
abstract_inverted_index.recognize	9
abstract_inverted_index.counterpart	12
abstract_inverted_index.<p>PDF	0
abstract_inverted_index.mTERT-derived	11
abstract_inverted_index.p568</p>	14
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	16
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.5899999737739563
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.11306393
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False